Subscribe to MDT Magazine News

Older adults can fight frailty through resistance weight training

September 30, 2010 10:31 am | by Baylor College of Medicine | Comments

Imagine not being able to stand up because you can't carry your own body weight. To prevent this, incorporate resistance weight training into your routine, said an expert at Baylor College of Medicine . "As we age, we slowly start to lose lean muscle mass, and resistance weight training...


St. Jude gets OK in Japan for spinal cord system

September 30, 2010 9:45 am | by The Associated Press | Comments

Medical device maker St. Jude Medical Inc. said Thursday it received regulatory approval in Japan for its Eon Mini spinal cord stimulation system.The company said the device is the "world's smallest, longest-lasting" rechargeable neurostimulator. The devices are used to manage chronic pain of...

Twins provide clue that genetic epilepsy can originate in the embryo

September 30, 2010 9:33 am | by EurekAlert | Comments

(University of Melbourne) An Australian study of identical twins shows that a rare genetic form of epilepsy can be caused by a genetic mutation that occurs in the embryo, and not necessarily passed down from parents.


Solos Endoscopy, Inc. Announces Results of 2010 Annual Shareholder Meeting

September 30, 2010 8:32 am | by Bio-Medicine.Org | Comments

BOSTON, Sept. 30 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce the results of the 2010 annual shareholder meeting held September 28, 2010 near Solos' headquarters in Boston, MA. During Solos' annual shareholder meeting, Robert Segersten, Amanda Segersten and Fred...


Reportlinker Adds Global Immunoassay Systems Industry

September 30, 2010 8:31 am | by Bio-Medicine.Org | Comments

NEW YORK, Sept. 30 /- announces that a new market research report is available in its catalogue: Global Immunoassay Systems Industry This report analyzes the worldwide markets for Immunoassay...


Generex bumps out Gluskin; Fletcher, Barratt fill CEO, chairman roles

September 30, 2010 7:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Worcester drug discovery firm Generex Biotechnology Corp. has named Mark Fletcher as CEO and interim president, replacing Generex co-founder, CEO, president and chairman Anna Gluskin.

Reportlinker Adds Global Protein Drugs Industry

September 30, 2010 7:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Sept. 30 /- announces that a new market research report is available in its catalogue: Global Protein Drugs Industry This report analyzes the Global market for Protein Drugs in US$ Million...


Minnow Medical Names Raymond W. Cohen as Chief Executive Officer

September 30, 2010 7:31 am | by Bio-Medicine.Org | Comments

LAGUNA HILLS, Calif., Sept. 30 /- Minnow Medical, Inc., a developer of a novel platform technology employing radiofrequency thermoplasty for the treatment of in-stent restenosis and other peripheral vascular conditions, announced today that veteran medical technology executive Raymond W....


Meridian gets Canadian approval for molecular test

September 30, 2010 6:45 am | by The Associated Press | Comments

Meridian Bioscience Inc. said Thursday it has received Canadian regulatory approval to sell its illumigeneT molecular test for clostridium difficile, which can cause diarrhea and colon inflammation.The company said the approval will help it meet the needs of its clinical laboratory customers....

Disparities 2010: Interview with Joseph D. Rosenblatt, M.D.

September 30, 2010 6:32 am | by AACR | Comments

Disparities 2010: Interview with Joseph D. Rosenblatt, M.D., interim director, Sylvester Comprehensive Cancer Center.


Dyax inks $106M development deal with Japan's CMIC

September 30, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Dyax Corp. has entered into a development and commercialization agreement worth a total of $106 million with Japanese firm CMIC Co. Ltd. to use subcutaneous DX-88 (ecallantide) to treat hereditary angioedema (HAE) and other angioedema indications in Japan.

Repligen Announces Completion of Patient Enrollment in Phase 2b Clinical Trial of RG2417 for Bipolar Depression

September 30, 2010 4:32 am | by Bio-Medicine.Org | Comments

WALTHAM, Mass., Sept. 30 /- Repligen Corporation (Nasdaq: RGEN ) reported today that it has completed enrollment of patients in its Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.  This study is a double-blind,...


caprotec bioanalytics Announces Commercial Launch of Three New caproKits™ for Applications in Functional Proteomics and Drug Development

September 30, 2010 4:32 am | by Bio-Medicine.Org | Comments

BERLIN and BURLINGTON, Mass., Sept. 30 / - caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits™, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development. The three new...


Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships

September 30, 2010 4:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Sept. 30 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has engaged Fabiani & Company to assist in the establishment of federal partnerships...


Winner Medical Launches Its Own PurCotton® B2C Website

September 30, 2010 4:31 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, Sept. 30 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton® materials for the medical and consumer products industries in China, today announced...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.